FDA panel unanimously recommends third Covid vaccine as J&J wins key vote in path to emergency use

The full FDA is likely to approve the Johnson & Johnson Covid vaccine as early as Saturday with distribution to the states next week.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.